{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:38:51Z","timestamp":1789263531853,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004459","name":"RAND Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["12055"],"award-info":[{"award-number":["12055"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001835","name":"Universiteit Maastricht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003245","name":"Netherlands Ministry of Education Culture and Science","doi-asserted-by":"publisher","award":["024.003.013"],"award-info":[{"award-number":["024.003.013"]}],"id":[{"id":"10.13039\/501100003245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003245","name":"Netherlands Ministry of Education Culture and Science","doi-asserted-by":"publisher","award":["024.005.020"],"award-info":[{"award-number":["024.005.020"]}],"id":[{"id":"10.13039\/501100003245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113763","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:56:20Z","timestamp":1745322980000},"page":"113763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The pharmacokinetic profile of mitomycin C released from an injectable supramolecular hydrogel in a rodent model"],"prefix":"10.1016","volume":"383","author":[{"given":"Anne G.W.E.","family":"Wintjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Paul K.H.","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaatje","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert C.","family":"van Almen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J.","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H.J.T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Y.W.","family":"Dankers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Van Der Speeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0005","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215914","article-title":"The molecular biology of peritoneal metastatic disease","volume":"15","author":"Bootsma","year":"2023","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00428-012-1287-y","article-title":"Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: future possibilities for personalised treatment by use of biomarkers","volume":"461","author":"de Cuba","year":"2012","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jconrel.2025.113763_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal Cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113763_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.52927\/jdcr.2022.10.2.74","article-title":"Recent update on the treatment of colorectal peritoneal metastasis: a surgical perspective","volume":"10","author":"Cho","year":"2022","journal-title":"J. Digest. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113763_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4251\/wjgo.v2.i2.109","article-title":"A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy","volume":"2","author":"Yan","year":"2010","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113763_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001813-199010000-00002","article-title":"Mitomycin C: mechanism of action, usefulness and limitations","volume":"1","author":"Verweij","year":"1990","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113763_bb0035","first-page":"15","article-title":"Regimens of intraperitoneal chemotherapy for peritoneal Carcinomatosis from colorectal Cancer","volume":"38","author":"Murono","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2025.113763_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/720858","article-title":"Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent","volume":"2013","author":"De Smet","year":"2013","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113763_bb0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13193-016-0498-0","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) methodology, drugs and bidirectional chemotherapy","volume":"7","author":"Valle","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1055-3207(03)00031-0","article-title":"Pharmacokinetics of intraperitoneal mitomycin C","volume":"12","author":"van Ruth","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2025.113763_bb0055","article-title":"Designing HIPEC regimens for colon cancer: is the available evidence being appropriately considered?","volume":"3","author":"Bijelic","year":"2021","journal-title":"Surg. Open Digest. Adv."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113763_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10585-022-10173-8","article-title":"Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review","volume":"39","author":"Wintjens","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113763_bb0065","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1039\/C1CS15203C","article-title":"Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications","volume":"41","author":"Li","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10585-023-10210-0","article-title":"Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model","volume":"40","author":"Wintjens","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"issue":"19","key":"10.1016\/j.jconrel.2025.113763_bb0075","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/ja500205v","article-title":"Tough stimuli-responsive supramolecular hydrogels with hydrogen-bonding network junctions","volume":"136","author":"Guo","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113763_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201700053","article-title":"Mechanically robust electrospun hydrogel scaffolds crosslinked via supramolecular interactions","volume":"17","author":"Mollet","year":"2017","journal-title":"Macromol. Biosci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113763_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1039\/C9BM01241A","article-title":"Multi-component supramolecular fibers with elastomeric properties and controlled drug release","volume":"8","author":"Putti","year":"2020","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113763_bb0090","doi-asserted-by":"crossref","first-page":"e2300005","DOI":"10.1002\/mabi.202300005","article-title":"Development of a supramolecular hydrogel for intraperitoneal injections","volume":"24","author":"Wintjens","year":"2023","journal-title":"Macromol. Biosci."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113763_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800007","article-title":"Cholesterol modification of an anticancer drug for efficient incorporation into a supramolecular hydrogel system","volume":"39","author":"Bakker","year":"2018","journal-title":"Macromol. Rapid Commun."},{"issue":"5041","key":"10.1016\/j.jconrel.2025.113763_bb0100","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/2101123a0","article-title":"Peritoneal fluid volume and the oestrus cycle in mice","volume":"210","author":"Hartveit","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113763_bb0105","series-title":"The Laboratory Rat","first-page":"127","article-title":"Chapter 5 - clinical pathology of the rat","author":"Car","year":"2006"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113763_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0090-8258(86)90097-1","article-title":"Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats","volume":"25","author":"Malviya","year":"1986","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113763_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0277-5379(87)90014-9","article-title":"Mitomycin C-induced renal toxicity, a dose-dependent side effect?","volume":"23","author":"Verwey","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02986439","article-title":"A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C","volume":"5","author":"Verweij","year":"1988","journal-title":"Med. Oncol. Tumor Pharmacother."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00269026","article-title":"Clinical pharmacokinetics of high-dose mitomycin C","volume":"13","author":"Schilcher","year":"1984","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113763_bb0130","doi-asserted-by":"crossref","first-page":"14881","DOI":"10.1038\/s41598-019-51419-y","article-title":"Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer","volume":"9","author":"De Clercq","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113763_bb0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/02656736.2017.1312563","article-title":"Tumour tissue transport after intraperitoneal anticancer drug delivery","volume":"33","author":"Carlier","year":"2017","journal-title":"Int. J. Hyperth."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113763_bb0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/gut.47.5.632","article-title":"Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans","volume":"47","author":"Keefe","year":"2000","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113763_bb0145","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1245\/s10434-021-10924-z","article-title":"Impact of Mitomycin-C-induced neutropenia after hyperthermic intraperitoneal chemotherapy with Cytoreductive surgery in colorectal Cancer patients with peritoneal Carcinomatosis","volume":"29","author":"Lee","year":"2022","journal-title":"Ann. Surg. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925003839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925003839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:21:15Z","timestamp":1762269675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925003839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"alternative-id":["S0168365925003839"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113763","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacokinetic profile of mitomycin C released from an injectable supramolecular hydrogel in a rodent model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113763"}}